Acuity Inc. (AYI) Q2 2026 Earnings Recap
Solid Beat. Acuity Inc. (NYSE:AYI) delivered Q2 2026 adjusted diluted earnings per share of $4.14, exceeding analyst expectations as the…
Solid Beat. Acuity Inc. (NYSE:AYI) delivered Q2 2026 adjusted diluted earnings per share of $4.14, exceeding analyst expectations as the…
Cal-Maine Foods delivered a stark reality check in its Q3 2026 results, with EPS of $1.06 collapsing 89.8% from the…
Lindsay Corporation (LNN) posted Q2 2026 diluted EPS of $1.15.
Lamb Weston's third quarter results reveal a company struggling with profitability erosion despite modest revenue gains. The frozen potato giant…
Mixed Quarter. Lamb Weston Holdings, Inc. (LW) reported Q3 2026 Adjusted Diluted EPS of $0.72 per share on revenue of…
Company Overview Galectin Therapeutics develops therapies targeting galectin proteins, focusing on its lead drug, belapectin, for MASH cirrhosis. Key Financial...
Company Overview Chagee Holdings Limited is a premium tea drinks brand. By December 31, 2025, the company operated 7,453 teahouses...
Company Overview Kodiak Sciences is a precommercial biotechnology company focused on researching, developing, and commercializing transformative therapeutics for retinal diseases....